1. Home
  2. Medical News
  3. Cardiology
advertisement

Functional Decline Preceded Cardiovascular Events in ASPREE

Simplified anatomical heart with fading contours illustrating gradual changes before cardiovascular events in older adults
11/20/2026

Key Takeaways

  • Among older adults recruited in Australia and the US, those who later had cardiovascular events had poorer pre-event functional profiles than matched event-free peers.
  • Future cardiovascular cases deteriorated faster across functional measures, with differences from event-free peers widening as an event approached.
  • Functional trajectories diverged earlier before heart failure and fatal coronary heart disease than before myocardial infarction or stroke.
In older adults without previous cardiovascular events, changes in frailty and physical function can be difficult to distinguish from the course of aging before cardiovascular disease (CVD) becomes clinically apparent. How early these measures might shift, and how their trajectories compare with those of otherwise similar peers, remains a clinical question. Investigators compared prior annual functional measurements in people who later experienced an event with measurements in peers who did not.

Phyo and colleagues conducted a nested matched case–control analysis reported in JAMA Cardiology within the Aspirin in Reducing Events in the Elderly (ASPREE) cohort in Australia and the US. The analysis included 12,015 reported participants: 2,403 subsequent CVD cases and 9,612 matched event-free controls. At enrollment, participants had no previous cardiovascular event, dementia, or significant physical disability. Annual assessments covered the Frailty Index (FI), Fried phenotype frailty, intrinsic capacity (IC), and physical health-related quality of life (HRQOL). Cases and controls were matched on age, sex, and education; expert clinical panels adjudicated events, and linear mixed-effects models compared functional trajectories recorded prospectively before those events.

Future CVD cases had consistently higher frailty, lower IC, and poorer physical HRQOL than matched controls years before their events. Differences widened markedly during the 5 years preceding CVD, alongside faster deterioration in cases. In the modeled case–control trajectory comparisons, the FI estimate was β=0.78 (95% CI 0.66–0.91), and the Fried frailty estimate was β=0.05 (95% CI 0.03–0.07). These coefficients describe differences in functional trajectories, rather than the probability of a cardiovascular event.

Declines in other functional measures also differed between future cases and event-free controls: the IC trajectory estimate was β=−0.34 (95% CI −0.44 to −0.24), and the physical HRQOL estimate was β=−0.55 (95% CI −0.70 to −0.40). The negative coefficients reflect steeper declines among future cases. For heart failure and fatal coronary heart disease, trajectories diverged at least 10 years before the respective events, earlier than they did before myocardial infarction or stroke.

Matched observational trajectories cannot establish whether functional deterioration contributes to CVD, accurately predicts an event for an individual, or supports a validated screening strategy. Nor can the comparison show that earlier intervention improves outcomes. According to the authors, the pre-event pattern may offer an opportunity for closer clinical evaluation or earlier intervention; those possibilities remain interpretations of the observed trajectories rather than demonstrated benefits.

The authors interpreted deterioration across several functional-aging measures before overt CVD as a possible reflection of progressive multisystem aging.

Clinician Questions

What age groups qualified for the ASPREE comparison of functional aging before cardiovascular events?

Eligible older adults recruited in Australia and the US were aged 70 years or older, except that US racial and ethnic minoritized groups qualified at age 65 years or older. Participants had no prior cardiovascular events, dementia, or significant physical disability.

Which intrinsic-capacity domains were measured before cardiovascular events in the ASPREE cohort?

Intrinsic capacity assessments in older ASPREE participants before later cardiovascular events comprised cognitive, locomotor, vitality, and psychological domains.

How were cardiovascular cases matched to event-free controls in the ASPREE functional-aging analysis?

Each older ASPREE participant who later had a cardiovascular event was matched to four event-free controls by age within one year, sex, and education.

This content is intended for healthcare professionals for educational purposes. The article and its image were developed with AI assistance and reviewed by members of the ReachMD team prior to publication. Please refer to the original source linked for the complete and most up-to-date information.

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free